Femasys FEMY
NASDAQ FEMY
$2.83 +0.15 (+5.60%)
At close: Sep 9, 2026 · 4:00 PM EDT

Femasys (FEMY) Construction in Progress (2020 - 2026)

Femasys' (FEMY) quarterly Construction in Progress came in at $919412.0 in Q2 2026, up 67.65% on a YoY basis from $548426.0 in Q2 2025, and down 3.75% quarter-over-quarter from $955271.0 in Q1 2026.

Analysis

Femasys (FEMY) Construction in Progress (2020 - 2026) Analysis & Trends

Femasys (FEMY) has reported Construction in Progress for 7 consecutive years, with $919412.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Construction in Progress rose 67.65% year-over-year to $919412.0; the trailing twelve-month figure through Jun 2026 stood at $919412.0 (up 67.65% YoY), and the FY2025 full-year result was $897885.0, up 17.76% from the prior year.
  • Construction in Progress retreated to $919412.0 in Q2 2026 per FEMY's latest filing, from $955271.0 in the prior quarter.
  • Across five years, Construction in Progress topped out at $955271.0 in Q1 2026 and bottomed at $384888.0 in Q2 2023.
  • Historically, Construction in Progress has averaged $586851.3 across 5 years, with a median of $548287.5 in 2024.
  • The sharpest annual moves came in 2022 and 2023: Construction in Progress soared 204.45% in 2022, then declined 21.53% in 2023.
  • Over 5 years, Construction in Progress stood at $413843.0 in 2022, then grew by 2.23% to $423077.0 in 2023, then soared by 80.21% to $762445.0 in 2024, then increased by 17.76% to $897885.0 in 2025, then rose by 2.4% to $919412.0 in 2026.
  • According to Business Quant data, Construction in Progress over the past three periods registered $919412.0, $955271.0, and $897885.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn -
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn -
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn -
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn -
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn 911.00 Mn
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn -
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn -
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn -
9 Steris 21.90 Bn 21.43 Bn 684.20 Mn 455.10 Mn
10 Femasys 9.01 Mn 7.57 Mn 189,391.00 919,412.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 919,412.00
Mar 31, 2026 955,271.00
Dec 31, 2025 897,885.00
Sep 30, 2025 687,462.00
Jun 30, 2025 548,426.00
Mar 31, 2025 600,551.00
Dec 31, 2024 762,445.00
Sep 30, 2024 548,149.00
Jun 30, 2024 651,157.00
Mar 31, 2024 569,723.00
Dec 31, 2023 423,077.00
Sep 30, 2023 394,957.00
Jun 30, 2023 384,888.00
Mar 31, 2023 406,588.00
Dec 31, 2022 413,843.00
Sep 30, 2022 503,312.00
Jun 30, 2022 461,735.00
Mar 31, 2022 434,443.00
Dec 31, 2021 379,713.00
Sep 30, 2021 268,226.00